167 related articles for article (PubMed ID: 27513102)
1. Tissue-engineered human psoriatic skin supplemented with cytokines as an in vitro model to study plaque psoriasis.
Pouliot-Bérubé C; Zaniolo K; Guérin SL; Pouliot R
Regen Med; 2016 Sep; 11(6):545-57. PubMed ID: 27513102
[TBL] [Abstract][Full Text] [Related]
2. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
[TBL] [Abstract][Full Text] [Related]
3. The Tissue-Engineered Human Psoriatic Skin Substitute: A Valuable In Vitro Model to Identify Genes with Altered Expression in Lesional Psoriasis.
Rioux G; Pouliot-Bérubé C; Simard M; Benhassine M; Soucy J; Guérin SL; Pouliot R
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261611
[TBL] [Abstract][Full Text] [Related]
4. Development of an in vitro psoriatic skin model by tissue engineering.
Jean J; Lapointe M; Soucy J; Pouliot R
J Dermatol Sci; 2009 Jan; 53(1):19-25. PubMed ID: 18783923
[TBL] [Abstract][Full Text] [Related]
5. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
Chiricozzi A; Guttman-Yassky E; Suárez-Fariñas M; Nograles KE; Tian S; Cardinale I; Chimenti S; Krueger JG
J Invest Dermatol; 2011 Mar; 131(3):677-87. PubMed ID: 21085185
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
7. The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization.
Pasquali L; Srivastava A; Meisgen F; Das Mahapatra K; Xia P; Xu Landén N; Pivarcsi A; Sonkoly E
Acta Derm Venereol; 2019 Feb; 99(2):196-205. PubMed ID: 30320872
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
9. Use of Cytokine Mix-, Imiquimod-, and Serum-Induced Monoculture and Lipopolysaccharide- and Interferon Gamma-Treated Co-Culture to Establish In Vitro Psoriasis-like Inflammation Models.
Bocheńska K; Moskot M; Gabig-Cimińska M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831208
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis.
Varshney P; Narasimhan A; Mittal S; Malik G; Sardana K; Saini N
Sci Rep; 2016 Jan; 6():19295. PubMed ID: 26781963
[TBL] [Abstract][Full Text] [Related]
11. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
[TBL] [Abstract][Full Text] [Related]
12. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
[TBL] [Abstract][Full Text] [Related]
13. Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model.
Bracke S; Desmet E; Guerrero-Aspizua S; Tjabringa SG; Schalkwijk J; Van Gele M; Carretero M; Lambert J
Arch Dermatol Res; 2013 Aug; 305(6):501-12. PubMed ID: 23775225
[TBL] [Abstract][Full Text] [Related]
14. Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium.
Ockenfels HM; Wagner SN; Keim-Maas C; Funk R; Nussbaum G; Goos M
Arch Dermatol Res; 1996 Apr; 288(4):173-8. PubMed ID: 8967788
[TBL] [Abstract][Full Text] [Related]
15. IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation.
Balato A; Lembo S; Mattii M; Schiattarella M; Marino R; De Paulis A; Balato N; Ayala F
Exp Dermatol; 2012 Nov; 21(11):892-4. PubMed ID: 23163661
[TBL] [Abstract][Full Text] [Related]
16. Local antimicrobial, protease and cytokine defense systems in psoriatic skin.
Sidhom E; Pilmane M; Kisis J
Indian J Dermatol Venereol Leprol; 2016; 82(3):284-91. PubMed ID: 27088930
[TBL] [Abstract][Full Text] [Related]
17. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis.
Varshney P; Saini N
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1795-1803. PubMed ID: 29432814
[TBL] [Abstract][Full Text] [Related]
18. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
19. IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes.
Muromoto R; Hirao T; Tawa K; Hirashima K; Kon S; Kitai Y; Matsuda T
Int Immunol; 2016 Sep; 28(9):443-52. PubMed ID: 26944069
[TBL] [Abstract][Full Text] [Related]
20. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
